HbO2 Therapeutics

About:

HbO2 Therapeutics develops and manufactures oxygen carrying solutions.

Website: http://www.hbo2therapeutics.com

Description:

HbO2 Therapeutics develops and manufactures oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. It offers two products. Hemopure [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin [hemoglobin glutamer – 200 (bovine)]) for veterinary use. The company was founded in 2014 and is headquartered in Souderton, Pennsylvania.

Total Funding Amount:

$1.45M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Souderton, Pennsylvania, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)hbo2therapeutics.com

Founders:

Jerry Kowalski, Zaf Zafirelis

Number of Employees:

1-10

Last Funding Date:

2015-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai